Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

25 filings reported holding COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share as of Q3 2025.
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 664,982 shares of 13,831,528 outstanding shares and own 4.81% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (268,080 shares), RENAISSANCE TECHNOLOGIES LLC (127,928 shares), GEODE CAPITAL MANAGEMENT, LLC (73,929 shares), BlackRock, Inc. (73,746 shares), NEUBERGER BERMAN GROUP LLC (31,886 shares), JANE STREET GROUP, LLC (21,044 shares), STATE STREET CORP (20,543 shares), Parallel Advisors, LLC (12,611 shares), NORTHERN TRUST CORP (11,921 shares), and BANK OF AMERICA CORP /DE/ (9,092 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.